Bulletin
Investor Alert

New York Markets Open in:

Fate Therapeutics Inc.

NAS: FATE

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209623007/composite

$

36.91

Change

0.00 0.00%

Volume

Volume 66,322

Sep 17, 2020, 4:37 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209623007/composite

Previous close

$ 36.93

$ 36.91

Change

-0.02 -0.04%

Day low

Day high

$35.61

$37.25

Open
Open: 36.10

52 week low

52 week high

$12.59

$38.90

Open

Market cap

$3.21B

Average volume

704,889

P/E ratio

N/A

Rev. per Employee

$45,577

EPS

-1.57

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/fate

MarketWatch News on FATE

  1. 7 Biotech Stocks to Buy for a Post-Pandemic World

    10:48 p.m. Aug. 17, 2020

    - Barron's Online

  2. Fate Therapeutics stock price target raised to $37 from $27 at Stifel Nicolaus

    8:42 a.m. March 3, 2020

    - Tomi Kilgore

  3. Fate Therapeutics downgraded to market perform from outperform at BMO Capital

    12:45 p.m. Jan. 9, 2020

    - Tomi Kilgore

  4. Fate Therapeutics started at buy with $27 stock price target at Stifel Nicolaus

    7:48 a.m. Oct. 1, 2019

    - Tomi Kilgore

  5. Fate Therapeutics started at outperform with $27 stock price target at Oppenheimer

    7:03 a.m. July 12, 2019

    - Tomi Kilgore

  6. Fate Therapeutics started at outperform with $20 stock price target at SVB Leerink

    8:17 a.m. March 28, 2019

    - Tomi Kilgore

  7. Activist Lawrence Seidman’s Unique Way of Viewing Small Banks

    9:00 p.m. Dec. 28, 2018

    - Barron's Online

  8. There’s Value in Damaged Papa John’s Pizza

    8:00 p.m. Oct. 5, 2018

    - Barron's Online

  9. Nutrisystem: Starved for Attention

    1:20 p.m. Aug. 21, 2018

    - Barron's Online

  10. Market recovery attempt intact, S&P 500 maintains major support

    12:36 p.m. Feb. 22, 2018

    - Michael Ashbaugh

  11. Gilead Overpays; Next Takeout Targets

    11:11 a.m. Aug. 30, 2017

    - Barron's Online

  12. Biotech: Size Matters?

    12:26 p.m. Jan. 26, 2016

    - Barrons Blogs

Analyst Ratings

/news/nonmarketwatch/company/us/fate

Other News on FATE

  1. 10-Q: FATE THERAPEUTICS INC

    4:13 p.m. Aug. 5, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. Fate Therapeutics Q2 2020 Earnings Preview

    5:35 p.m. Aug. 4, 2020

    - Seeking Alpha

  3. Biotech IPO Nkarta triples in debut

    12:45 p.m. July 10, 2020

    - Seeking Alpha

  4. Fate's IND Application for CAR T Cell Therapy Gets FDA Nod

    10:18 a.m. July 10, 2020

    - Zacks.com

  5. IPO Update: Nkarta Proposes Terms For $150 Million IPO

    12:05 p.m. July 5, 2020

    - Seeking Alpha

  6. Small Caps Build Steam And Biotechs Remain Well-Positioned

    10:15 a.m. June 10, 2020

    - Seeking Alpha

  7. Fate Therapeutics prices equity offering at $28.31

    4:43 a.m. June 9, 2020

    - Seeking Alpha

  8. FDA clears Fate Therapeutics' IND for FT538

    8:31 a.m. May 20, 2020

    - Seeking Alpha

  9. What Wedbush Sees Coming in ASCO’s 2020 Annual Meeting

    11:15 a.m. May 15, 2020

    - 247WallSt.com

  10. Biotech's Golden Moment As Healthcare Attracts Investors

    9:31 a.m. May 12, 2020

    - Seeking Alpha

  11. 10-Q: FATE THERAPEUTICS INC

    4:33 p.m. May 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. Fate Therapeutics Q1 2020 Earnings Preview

    5:35 p.m. May 10, 2020

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/fate

Press Releases on FATE

  1. Fate Therapeutics Announces September Investor Events

    8:00 a.m. Sept. 4, 2020

    - GlobeNewswire

  2. Fate Therapeutics Announces September Investor Events

    8:00 a.m. Sept. 4, 2020

    - GlobeNewswire

  3. Natural Killer Cell Therapies Market Size and Demand Outlook 2020-2026

    2:12 a.m. Aug. 26, 2020

    - Market Insight Reports

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.